These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 2780637)

  • 1. Anomalies in the plasma proteins that bind propranolol in sheep.
    Hill MD; Briscoe P; Abramson FP
    Prog Clin Biol Res; 1989; 300():409-12. PubMed ID: 2780637
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of propranolol-binding plasma proteins in sheep with those in humans, dogs and rats.
    Hill MD; Briscoe PR; Abramson FP
    Biochem Pharmacol; 1989 Dec; 38(23):4199-205. PubMed ID: 2557042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of surgery on serum alpha 1-acid glycoprotein concentration and serum protein binding of DL-propranolol in phenobarbital-treated and untreated rats.
    Lin TH; Sugiyama Y; Sawada Y; Suzuki Y; Iga T; Hanano M
    Drug Metab Dispos; 1987; 15(1):138-40. PubMed ID: 2881752
    [No Abstract]   [Full Text] [Related]  

  • 4. Relationships between propranolol plasma protein binding, glycoprotein concentration, and enzyme induction following phenobarbital administration in the dog.
    Abramson FP; Robinson D; Bai SA
    Biochem Pharmacol; 1983 Sep; 32(17):2618-20. PubMed ID: 6615557
    [No Abstract]   [Full Text] [Related]  

  • 5. Alpha-1-acid glycoprotein concentrations and protein binding of propranolol in Sprague-Dawley and Dark Agouti rat strains treated by phenobarbital.
    Chauvelot-Moachon L; Delers F; Poüs C; Engler R; Tallet F; Giroud JP
    J Pharmacol Exp Ther; 1988 Mar; 244(3):1103-8. PubMed ID: 3252025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of altered plasma protein binding on pharmacokinetics and pharmacodynamics of propranolol in rats after surgery: role of alpha-1-acid glycoprotein.
    Yasuhara M; Fujiwara J; Kitade S; Katayama H; Okumura K; Hori R
    J Pharmacol Exp Ther; 1985 Nov; 235(2):513-20. PubMed ID: 2997437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions of phenobarbital with propranolol in the dog. 1. Plasma protein binding.
    Bai SA; Abramson FP
    J Pharmacol Exp Ther; 1982 Sep; 222(3):589-94. PubMed ID: 7108766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SKF 525A displaces drugs from serum alpha 1-acid glycoprotein binding sites.
    Belpaire FM; Chindavijak B; Bogaert MG
    J Pharmacol Exp Ther; 1987 Feb; 240(2):628-30. PubMed ID: 3806415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Modification of the saccharide structures of orosomucoid in rats stimulated by treatment with phenobarbital].
    Monnet D; Feger J; Biou D; Agneray J; Durand G
    C R Acad Sci III; 1985; 301(5):151-6. PubMed ID: 3933771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of endotoxin on the stereoselective pharmacokinetics of oxprenolol, propranolol, and verapamil in the rat.
    Laethem ME; Belpaire FM; Wijnant P; Rosseel MT; Bogaert MG
    Chirality; 1994; 6(5):405-10. PubMed ID: 8068500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of phenobarbital on the pharmacokinetics of propranolol in pregnancy.
    Hoffmann-Traeger A; Peiker G; Glöckner R; Wittmann I; Balogh A; Henschel L
    Biol Res Pregnancy Perinatol; 1987; 8(2 2D Half):57-9. PubMed ID: 3427136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro binding of propranolol and progesterone to native and desialylated human orosomucoid.
    Wong AK; Hsia JC
    Can J Biochem Cell Biol; 1983 Oct; 61(10):1114-6. PubMed ID: 6652563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effect of propranolol on the anticonvulsant effect of phenobarbital in maximal electroshock in the mouse and rat].
    Fischer W; Lasek R; Kluge S
    Pharmazie; 1986 Jun; 41(6):440-1. PubMed ID: 3763689
    [No Abstract]   [Full Text] [Related]  

  • 14. The disposition of propranolol. 3. Decreased half-life and volume of distribution as a result of plasma binding in man, monkey, dog and rat.
    Evans GH; Nies AS; Shand DG
    J Pharmacol Exp Ther; 1973 Jul; 186(1):114-22. PubMed ID: 4198771
    [No Abstract]   [Full Text] [Related]  

  • 15. Quantitative metabolic fate of propranolol in the dog, rat, and hamster using radiotracer, high performance liquid chromatography, and gas chromatography-mass spectrometry techniques.
    Bargar EM; Walle UK; Bai SA; Walle T
    Drug Metab Dispos; 1983; 11(3):266-72. PubMed ID: 6135586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The influence on labyrinth behavior of rats of anticonvulsant acting drugs: comparison of propranolol, phenobarbital, phenytoin and diazepam].
    Kluge S; Müller M; Baehnisch S; Fischer W
    Pharmazie; 1986 Apr; 41(4):297-8. PubMed ID: 3725884
    [No Abstract]   [Full Text] [Related]  

  • 17. Interactions of phenobarbital with propranolol in the dog. 2. Bioavailability, metabolism and pharmacokinetics.
    Vu VT; Bai SA; Abramson FP
    J Pharmacol Exp Ther; 1983 Jan; 224(1):55-61. PubMed ID: 6848749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of phenobarbital with propranolol in the dog. 3. Beta blockade.
    Bai SA; Abramson FP
    J Pharmacol Exp Ther; 1983 Jan; 224(1):62-7. PubMed ID: 6129320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma drug binding: implications for anesthesiologists.
    Wood M
    Anesth Analg; 1986 Jul; 65(7):786-804. PubMed ID: 3087239
    [No Abstract]   [Full Text] [Related]  

  • 20. Plasma protein binding and blood cell distribution of propranolol enantiomers in rats.
    Takahashi H; Ogata H
    Biochem Pharmacol; 1990 May; 39(9):1495-8. PubMed ID: 2334449
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.